Product description

JAMP-BEZAFIBRATE SR (bezafibrate) is indicated as an adjunct to diet and other therapeutic measures for:
  • Treatment of patients with hypercholesterolemia Type IIa and IIb mixed hyperlipidemia, to regulate lipid and apoprotein levels (reduce serum TG, LDL cholesterol and apolipoprotein B, increase HDL cholesterol and apolipoprotein A).
  • Treatment of adult patients with high to very high triglyceride levels, Fredrickson classification Type IV and V hyperlipidemias, who are at a high risk of sequelae and complications (i.e. pancreatitis) from their dyslipidemia.
Read more


Categories Finished Dosage FormsTablets; Generic APIs; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; North America

More products from JAMP Pharma

Products from other suppliers